Aristea Therapeutics

closed

A clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases.

Launch date

2018

Employees

Market cap

Enterprise valuation

San Diego California (HQ)

Date	Investors	Amount	Round
Dec 2018*	Novo Holdings Novo Seeds	$15.0m	Series A
Oct 2020	N/A	$39.6m	Late VC
Jul 2021	Fidelity Investments Tekla Capital Management Arena Pharmaceuticals Novo Holdings	$63.0m	Series B
Total Funding		€107m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Aristea Therapeutics